Lista de obras - Deepa Bhojwani - Dominio Público Uruguay

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childho

artículo científico publicado en 2014

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

artículo científico publicado en 2013

A revised definition for cure of childhood acute lymphoblastic leukemia.

artículo científico publicado en 2014

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study

artículo científico publicado en 2006

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

artículo científico publicado en 2015

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.

artículo científico publicado en 2011

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

artículo científico publicado en 2019

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

artículo científico publicado en 2010

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.

artículo científico publicado en 2011

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models ⬇️

artículo científico publicado el 16 de agosto de 2011

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

artículo científico publicado en 2009

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

artículo científico publicado en 2006

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]

scientific article published on September 2008

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

artículo científico publicado en 2008

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles ⬇️

artículo científico publicado el 7 de junio de 2011

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

scientific article published on 18 February 2020

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

artículo científico publicado en 2010

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

artículo científico publicado en 2014

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

artículo científico publicado en 2010

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

Individualized therapy for childhood acute lymphoblastic leukemia

article

Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling ⬇️

artículo científico publicado el 21 de septiembre de 2011

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

artículo científico publicado en 2013

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

artículo científico publicado en 2018

Intrathecal liposomal cytarabine: more friend than foe?

artículo científico publicado en 2008

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza

artículo científico publicado en 2009

Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis

artículo científico publicado en 2016

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

artículo científico publicado en 2009

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

scientific article published on 18 February 2014

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

artículo científico publicado en 2015

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

scientific journal article

Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations

scientific journal article

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

artículo científico publicado en 2016

Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia.

artículo científico publicado en 2007

Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia.

artículo científico publicado en 2013

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia

artículo científico publicado en 2014

Spinal epidural lipomatosis in children with hematologic malignancies.

artículo científico publicado en 2011

The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

artículo científico publicado en 2018

The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.

artículo científico publicado en 2016

The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma

artículo científico publicado en 2014

Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.

artículo científico publicado en 2013

Thrombophilia in childhood.

artículo científico publicado en 2004

Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids

artículo científico publicado en 2015

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.

artículo científico publicado en 2014

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.

artículo científico publicado en 2016

Lista de obras de Deepa Bhojwani

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childho

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

A revised definition for cure of childhood acute lymphoblastic leukemia.

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.

Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy.

Endogenous knockdown of survivin improves chemotherapeutic response in ALL models ⬇️

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles ⬇️

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

Individualized therapy for childhood acute lymphoblastic leukemia

Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling ⬇️

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Intrathecal liposomal cytarabine: more friend than foe?

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza

Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis

Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.

NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity

Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Potential of gene expression profiling in the management of childhood acute lymphoblastic leukemia.

Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia.

Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia

Spinal epidural lipomatosis in children with hematologic malignancies.

The Impact of Persistent Leukoencephalopathy on Brain White Matter Microstructure in Long-Term Survivors of Acute Lymphoblastic Leukemia Treated with Chemotherapy Only.

The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.

The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma

Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.

Thrombophilia in childhood.

Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.

Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.